Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Virax Biolabs Group Limited - Ordinary Shares
(NQ:
VRAX
)
0.4000
+0.0320 (+8.70%)
Streaming Delayed Price
Updated: 11:06 AM EST, Jan 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Virax Biolabs Group Limited - Ordinary Shares
< Previous
1
2
3
4
5
6
7
Next >
Wondering what's happening in today's after-hours session?
↗
December 31, 2025
Via
Chartmill
Let's take a look at the stocks that are in motion in today's session.
↗
December 04, 2025
Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via
Chartmill
What's going on in today's pre-market session
↗
December 04, 2025
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via
Chartmill
How Is The Market Feeling About Virax Biolabs Group?
↗
October 28, 2024
Via
Benzinga
Stay updated with the stocks that are on the move in today's after-hours session.
↗
December 03, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via
Chartmill
Let's take a look at the stocks that are in motion in today's session.
↗
December 03, 2025
Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes.
Via
Chartmill
These stocks are the most active in today's session
↗
December 03, 2025
Get a pulse on the US markets on Wednesday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity.
Via
Chartmill
These stocks are moving in today's session
↗
December 03, 2025
Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via
Chartmill
Which stocks are gapping on Wednesday?
↗
December 03, 2025
The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via
Chartmill
Get insights into the top gainers and losers of Wednesday's pre-market session.
↗
December 03, 2025
Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.
Via
Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
↗
September 08, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
August 26, 2025
Via
Benzinga
EXCLUSIVE: Virax Biolabs Inks Research Pact To Advance Long COVID Diagnostic Studies
↗
August 26, 2025
Virax Biolabs partners with Emory University to study its T cell diagnostic ViraxImmune for long COVID, aiming for FDA guidance and U.S. market entry.
Via
Benzinga
What's Driving the Market Sentiment Around Virax Biolabs Group?
↗
June 30, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
April 14, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
April 11, 2025
Via
Benzinga
Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating
↗
March 31, 2025
Virax Biolabs' T-cell testing platform targets post-viral syndromes like Long COVID. HC Wainwright sees a major market opportunity, setting a $3 price target.
Via
Benzinga
EXCLUSIVE: Virax Biolabs Says Its Tech Fits RFK Jr.'s HHS Goals On Vaccine Transparency
↗
February 25, 2025
Virax Biolabs supports HHS's focus on vaccine efficacy transparency, offering technology to assess immune responses and collaborate with developers to improve vaccine research.
Via
Benzinga
Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
↗
December 19, 2024
Via
Benzinga
Nasdaq Down 2%; US Crude Stocks Increase
↗
October 23, 2024
Via
Benzinga
Gold Moves Lower; AT&T Earnings Top Views
↗
October 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
October 23, 2024
Via
Benzinga
Dow Tumbles Over 250 Points; Boeing Posts Q3 Loss
↗
October 23, 2024
Via
Benzinga
Topics
Stocks
EXCLUSIVE: Virax Biolabs Inks Distribution Pact To Commercialize ImmuneSelect Profiling Solutions In UK And Ireland
↗
October 23, 2024
Virax Biolabs partners with Europa Biosite to distribute ImmuneSelect for research use, focusing on T-cell immunity and post-viral syndromes, including Long COVID.
Via
Benzinga
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In August 2024 – Where Do Tesla, Nvidia, Apple, AMD Stock Rank?
↗
September 03, 2024
A look at the top 20 most-searched tickers on Benzinga Pro for the month of August.
Via
Benzinga
Nasdaq Down Over 1%; Foot Locker Shares Tumble After Q2 Results
↗
August 28, 2024
Via
Benzinga
What's Going On With Virax Biolabs Stock Wednesday
↗
August 28, 2024
Virax Biolabs stock is trading higher on Wednesday after the company announced it entered into a distribution agreement with a supplier of RT-PCR Mpox detection kits.
Via
Benzinga
Topics
Supply Chain
US Stocks Mixed; JM Smucker Slashes Annual Guidance
↗
August 28, 2024
Via
Benzinga
EXCLUSIVE: Virax Biolabs Inks Distribution Pact For Mpox Diagnostic Kits In Europe And Middle East
↗
August 28, 2024
Virax Biolabs has signed a distribution agreement to commercialize RT PCR Mpox virus detection kits in Europe and Gulf countries, amid a WHO-declared international health emergency due to rising mpox...
Via
Benzinga
Virax Biolabs Announces Stock Offering: What To Know
↗
August 22, 2024
Virax Biolabs shares are trading lower Thursday after the company announced a $5 million registered direct offering of ordinary shares. Here's a look at what's going on:
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
